Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Immunogen Inc (IMGN)

Immunogen Inc (IMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,537,936
  • Shares Outstanding, K 199,732
  • Annual Sales, $ 132,300 K
  • Annual Income, $ -44,370 K
  • 60-Month Beta 1.39
  • Price/Sales 11.50
  • Price/Cash Flow N/A
  • Price/Book 15.80
Trade IMGN with:

Options Overview

Details
  • Implied Volatility 110.91%
  • Historical Volatility 50.45%
  • IV Percentile 59%
  • IV Rank 33.51%
  • IV High 202.26% on 04/20/20
  • IV Low 64.87% on 12/18/20
  • Put/Call Vol Ratio 0.04
  • Today's Volume 1,127
  • Volume Avg (30-Day) 1,100
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 33,213
  • Open Int (30-Day) 16,215

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.19
  • Number of Estimates 6
  • High Estimate -0.16
  • Low Estimate -0.22
  • Prior Year -0.17
  • Growth Rate Est. (year over year) -11.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.02 +6.98%
on 04/13/21
8.90 -15.62%
on 03/17/21
-1.40 (-15.71%)
since 03/16/21
3-Month
7.02 +6.98%
on 04/13/21
10.88 -30.97%
on 02/12/21
+0.30 (+4.16%)
since 01/15/21
52-Week
3.34 +124.85%
on 04/17/20
10.88 -30.97%
on 02/12/21
+4.02 (+115.19%)
since 04/16/20

Most Recent Stories

More News
ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that a poster highlighting preclinical data for its novel...

IMGN : 7.45 (-3.25%)
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on March 31, 2021 the compensation committee of the Company's...

IMGN : 7.45 (-3.25%)
Why Is ImmunoGen (IMGN) Up 9.2% Since Last Earnings Report?

ImmunoGen (IMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IMGN : 7.45 (-3.25%)
Global Antibody Drug Conjugates Market Size Will Reach USD 4,670 Million By 2026: Facts & Factors

Facts and Factors have published a new research report titled "Antibody Drug Conjugates Market by Drugs (Adcetris and Kadcyla), Mechanism of Action (CD30 Antibodies and HER2 Antibodies), Application (Breast...

IMGN : 7.45 (-3.25%)
IMMU : 87.86 (+0.05%)
PFE : 38.62 (+2.71%)
PGNX : 4.10 (-9.39%)
SGEN : 144.91 (-3.16%)
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on February 26, 2021 the compensation committee of the...

IMGN : 7.45 (-3.25%)
ImmunoGen Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Life Sciences Conference

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Susan Altschuller, Chief Financial Officer, and Anna...

IMGN : 7.45 (-3.25%)
Immunogen Inc Has Returned 12.5% Since SmarTrend Recommendation (IMGN)

SmarTrend identified an Uptrend for Immunogen Inc (NASDAQ:IMGN) on January 19th, 2021 at $7.67. In approximately 4 weeks, Immunogen Inc has returned 12.46% as of today's recent price of $8.62.

IMGN : 7.45 (-3.25%)
ImmunoGen (IMGN) Surpasses Q4 Earnings and Revenue Estimates

ImmunoGen (IMGN) delivered earnings and revenue surprises of 500.00% and 69.54%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

IMGN : 7.45 (-3.25%)
ImmunoGen Reports Recent Progress and 2020 Financial Results

--Full Approval Pathway for IMGN632 in BPDCN Aligned with FDA; Updated Phase 1/2 Data in BPDCN Presented at ASH

IMGN : 7.45 (-3.25%)
ImmunoGen, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 12, 2021 / ImmunoGen, Inc. (NASDAQ:IMGN) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 12, 2021 at 8:00...

IMGN : 7.45 (-3.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended...

See More

Key Turning Points

3rd Resistance Point 8.17
2nd Resistance Point 8.03
1st Resistance Point 7.87
Last Price 7.45
1st Support Level 7.57
2nd Support Level 7.43
3rd Support Level 7.27

See More

52-Week High 10.88
Fibonacci 61.8% 8.00
Last Price 7.45
Fibonacci 50% 7.11
Fibonacci 38.2% 6.22
52-Week Low 3.34

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar